Mannose-binding lectin (MBL) is a serum collectin believed to be of importance in innate immunity. We have investigated the role of MBL in the first-line defense against Candida albicans, an opportunistic fungal pathogen. MBL bound C. albicans via its lectin domain, resulting in agglutination of the organisms upon their outgrowth of hyphae. In a human in vitro MBL system, deposition of C4 fragments on C. albicans was increased when exogenous MBL was added to serum samples from MBL-deficient individuals. Similar enhancement of deposition of iC3b also was observed. MBL and enhanced opsonic C3 fragments mediated by MBL did not facilitate opsonophagocytosis of the organisms by monocyte-derived dendritic cells (DCs). However, MBL was found to inhibit the growth of C. albicans independently of complement activation, although, with complement activation, further inhibition was observed. We concluded that MBL plays an important role in the first-line defense against C. albicans without the need for opsonophagocytosis by DCs, in which a direct interaction of MBL with C. albicans results in agglutination and accelerated complement activation via the lectin pathway, leading to inhibition of growth.
tivated serine protease is then able to cleave, sequentially, C4 and C2, resulting in the generation of covalently bound C4b2a complexes, C3 convertases, which allows conversion of C3 into C3a and C3b/iC3b, the key reaction leading to initiation of the terminal pathway. Accumulating evidence has shown that MBL can modulate the host inflammatory response to infections in both ex vivo and in vivo models [6, [9] [10] [11] [12] .
In humans, a single MBL gene on chromosome 10 encodes the protein [13, 14] . MBL deficiency and low levels of serum MBL are strongly associated with the gene polymorphisms in the exon 1 [15] [16] [17] [18] and promoter regions [19] . At present, 7 different haplotypes have been described, and 4 of these (LYPB, LYQC, HYPD, and LXPA) are associated with low levels of the protein [20] . In many populations, MBL deficiency is the most common immunodeficiency described at present, and several clinical studies have established an association between MBL deficiency and susceptibility to disease [21, 22] .
Candida albicans is a component of the normal mi-croflora of the alimentary tract and mucocutaneous membranes of the healthy host. However, when immune defenses are compromised or the normal microflora balance is disrupted, Candida organisms transform into opportunistic pathogens. Indeed, dissemination of Candida organisms is the leading cause of invasive fungal disease in premature infants, diabetic patients, and surgical patients and of oropharyngeal disease in patients with AIDS [23] [24] [25] [26] [27] [28] [29] . C. albicans can switch from a unicellular yeast form into various filamentous hyphal forms, all of which can be found in infected tissues [30] . The ability of C. albicans to alter its cell structure from a yeast form to a hyphal form enables the fungus to adhere to host cells and penetrate tissues [31] . This dimorphic growth is thought to be an important virulence factor [32, 33] . For this to be possible, mechanisms must exist in the host defense to target such essential aspects of the pathogenicity of C. albicans. Recent evidence indicates that dendritic cells (DCs), which are potent professional antigen-presenting cells, can induce cell-mediated immunity on interaction with C. albicans, by phagocytosis, killing, and antigen presentation [34] and are also capable of sensing different forms of the fungus by discriminative production of cytokines [35, 36] . MBL has the capacity to function as an opsonin-in particular, for phagocytosis by neutrophils [6, 7] -and has been shown to strongly bind C. albicans [37] . The role of MBL in the host defense against C. albicans, however, remains unclear. In the present study, we examined the role of MBL in the innate defense against C. albicans, including opsonophagocytosis by DCs.
MATERIALS AND METHODS
C. albicans. C. albicans strain ATCC 90028 was maintained on Sabouraud dextrose agar (Difco Laboratories) at 4ЊC. Organisms were grown for 16 h in brain-heart infusion broth (Oxoid) at 37ЊC, with orbital shaking at 200 rpm before use. Under these conditions, C. albicans grew as a 195% pure yeastphase population. Immediately before each experiment, organisms were harvested by centrifugation, washed 3 times in Hanks' balanced salt solution (HBSS; Gibco-BRL), and resuspended to the appropriate concentration in HBSS containing 5 mmol/L CaCl 2 and 5 mmol/L MgCl 2 (HBSS ++ ). Binding of MBL to C. albicans. C. albicans yeasts (2 ϫ 10 7 cells/mL) were incubated with 5 mg/mL purified MBL (a gift from Prof. M. W. Turner, Institute of Child Health, London; purified MBL is known to be noncovalently associated with MASPs in their preparation, as described elsewhere [4] ), in a total volume of 50 mL of HBSS ++ , for 10 min at 37ЊC. The yeasts were then spun for 2 min at 10,000 g, and the pellets were washed with HBSS before resuspension in fluorescein isothiocyanate (FITC)-conjugated anti-human-MBL monoclonal antibody (4 mg/mL in HBSS; HYB 131-01; AntibodyShop). After 15 min of incubation on ice, the samples were centrifuged and washed as described above and were fixed in 1% (vol/vol) formaldehyde and 1% (wt/vol) glucose in PBS, for flow cytometry. MBL binding was measured by use of flow cytometry performed on an EPICS Elite ESP (Coulter) at a low flow rate. Data were evaluated as mean fluorescence intensity (MFI).
Negative controls were established for MBL binding by the omission of MBL. For inhibition experiments, 20 mmol/L EDTA or 2 mg/mL mannan from Saccharomyces cerevisiae (Sigma-Aldrich) was added to the MBL solution 5 min before the addition of MBL to the yeasts.
Influence of MBL on formation of hyphae of C. albicans. C. albicans yeasts ( cells/mL) were incubated with or with-6 1 ϫ 10 out 5 mg/mL purified MBL in 100 mL of HBSS ++ with 10% heatinactivated fetal calf serum (FCS; Gibco-BRL), in 96-well tissueculture plates (Corning-Costar) (100 mL/well), for up to 3 h at 37ЊC (5% CO 2 ). The use of serum-rich medium and culturing at 37ЊC (5% CO 2 ) stimulates germination of C. albicans yeasts. C. albicans was analyzed by use of light microscopy, to determine the influence of MBL on formation of hyphae. Agglutination of C. albicans yeast (unicellular) or hyphae (filamentous), in the presence of MBL, was also evaluated by use of flow cytometry (scatter plots) or light microscopy, respectively.
Deposition of C4 and iC3b on C. albicans. Serum samples were available for study from 6 MBL-deficient but generally healthy blood donors. Ethical approval was obtained for the present study from the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. All of the blood donors were homozygous for the LYPB haplotype of the MBL gene and had undetectable levels of serum MBL (!0.05 mg/mL), which were determined as described elsewhere [38, 39] . The freshly prepared MBL-deficient serum samples from these individuals were aliquoted and stored at Ϫ70ЊC until use.
C. albicans yeasts ( cells/mL) were incubated in 50 mL 7 2 ϫ 10 of HBSS ++ containing 20% MBL-deficient serum supplemented with or without 5 mg/mL purified MBL, in Eppendorf tubes for 1, 2, 4, 8, 16, or 32 min at 37ЊC. The reaction in each tube was stopped by adding 1 mL of ice-cold HBSS containing 1% paraformaldehyde. Suspensions were spun for 2 min at 10,000 g. The supernatants were removed, and pellets were washed in 0.5 mL of HBSS before suspension in monoclonal anti-C4d (4 mg/mL in HBSS; Quidel), which recognizes C4, C4b, and C4d. After 15 min of incubation on ice, the samples were centrifuged and washed as described above and were resuspended in FITCanti-mouse IgG1 (4 mg/mL in HBSS; BD PharMingen). The mixtures were incubated for a further 15 min on ice. Suspensions were centrifuged and washed, and samples were then fixed in 1% (vol/vol) formaldehyde and 1% (wt/vol) glucose in PBS, for flow cytometry. Deposition of C4 was evaluated for each MBL-deficient serum sample in duplicate by use of flow cytometry performed as described above for MBL binding.
After the mixtures were incubated, as described above, for up to 32 min, deposition of iC3b was also determined in separate tubes in which monoclonal anti-iC3b (4 mg/mL in HBSS; Quidel) and FITC-anti-mouse IgG2b (4 mg/mL in HBSS; BDPharmingen) were used instead of monoclonal anti-C4d and FITC-anti-mouse IgG1, respectively. Evaluation of deposition of iC3b was also the same as for deposition of C4d (i.e., by flow cytometry).
Preparation of human DCs. DCs were prepared as described elsewhere [40] . In brief, peripheral blood was obtained from healthy blood donors, and peripheral blood mononuclear cells (PBMCs) were isolated by sedimentation over Ficoll-Paque gradient (Pharmacia Biotech). To generate immature DCs, monocytes positively selected from PBMCs by use of anti-CD14 microbeads (Mitenyi Biotec) were cultured in 24-well tissue-culture plates (Corning-Costar) (1 mL/well) at a concentration of cells/mL in RPMI 1640 medium (Gibco-BRL) con- 6 1 ϫ 10 taining 10% FCS (Gibco-BRL), human recombinant granulocyte-macrophage colony-stimulating factor (50 ng/mL; R&D Systems), and human recombinant interleukin-4 (10 ng/mL; R&D Systems) for 7 days. At days 6-7, 195% of the cells were CD14 Ϫ CD11c + HLA-DR + DCs, as determined by use of 3-color flow cytometry. DCs were studied after 6-7 days of culture.
Opsonophagocytosis of C. albicans by DCs. C. albicans yeasts were labeled with green-fluorescent dye PKH67 (Sigma), in accordance with the manufacturer's protocol. Phagocytosis was evaluated by use of an MOI of 5 organisms:1 DC. PKH67-labeled yeasts ( cells/mL) were incubated in 125 mL of 7 2 ϫ 10 HBSS ++ containing 20% MBL-deficient serum supplemented with or without purified MBL (1 or 5 mg/mL), in Eppendorf tubes for 16 min at 37ЊC. The reaction was stopped by adding 1 mL of ice-cold HBSS. The suspensions were spun for 2 min at 10,000 g. The supernatants were discarded, and the pellets were resuspended in 0.25 mL of serum-free RPMI 1640 medium ( cells/mL) and then were transferred to 24-well 6 10 ϫ 10 tissue-culture plates (Corning-Costar) (0.25 mL/well). DCs (2 ϫ 10 6 cells/mL) in 0.25-mL aliquots, in serum-free RPMI 1640 medium, were added, and the mixtures, in a final volume of 0.5 mL, were incubated for 1 h at 37ЊC with orbital shaking at 150 rpm. A 1-mm volume of ice-cold HBSS was added to stop phagocytosis. The samples were spun, and pellets were resuspended in 200 mL of trypan blue (Gibco-BRL) (1 mg/mL in HBSS) and incubated for 10 min at 25ЊC, to quench the fluorescence of bound, but not engulfed, organisms, as described elsewhere [34] . The samples then were washed and fixed in 1% (vol/vol) formaldehyde and 1% (wt/vol) glucose in PBS, for flow cytometry. Phagocytosis of the PKH67-labeled C. albicans was evaluated by determining the percentage of DCs associated with these labeled organisms in the entire population of DCs. The maximum percentages obtained within an experiment were assigned a value of 100%, with all other percentages within the same experiment expressed as a relative percentage of this maximum. Negative controls were established for opsonophagocytosis of C. albicans, by incubating organisms in HBSS ++ containing neither serum nor purified MBL in the opsonization step.
Influence of MBL on growth of C. albicans. Freshly grown C. albicans yeasts ( cells/mL) were incubated with or 7 2 ϫ 10 without 5 mg/mL purified MBL in HBSS ++ for 15 min at 37ЊC. The yeast cells were washed with HBSS, resuspended in RPMI 1640 medium at cells/mL, and then transferred to 96- 6 1 ϫ 10 well tissue-culture plates (50 mL/well). To each well was added 50 mL of 2.5% MBL-deficient serum diluted in RPMI 1640 medium, 2.5% MBL-deficient serum heat inactivated for 30 min at 56ЊC and diluted in RPMI 1640 medium, or RPMI 1640 medium alone. The final concentration of serum used (1.25%/ well) was determined to be the highest concentration giving minimal growth-inhibitory effect on C. albicans by our separate experiments in which yeast cells were incubated with a range of concentrations (0.625%-80%) of pooled human serum serially diluted in RPMI 1640 medium or with RPMI alone, for 6 h 37ЊC, and the growth of C. albicans was determined by use of the XTT-based cell proliferation assay (XTT-assay; Roche), as adapted from previous reports [41, 42] . The yeasts, in a final volume of 100 mL of culture medium/well, were incubated at 37ЊC (5% CO 2 ). After 3 and 6 h of incubation, the growth of C. albicans was determined by use of the XTT-assay. In brief, 50 mL of the XTT-labeling mixture, prepared according to the manufacturer's protocol (Roche), was added to each well. The plates were then incubated in the dark for up to 2 h at 37ЊC (5% CO 2 ). A colorimetric change in the XTT-assay was then measured in terms of the absorbance at 490 nm by use of a microtiter plate reader (Model 550; Bio-Rad).
Statistical analysis. Data are expressed as . mean ‫ע‬ SEM Statistical significance was determined by paired Student's t tests, by use of Instat (version 3.05; GraphPad Software). P ! was considered to be significant. .05
RESULTS
Binding of MBL to C. albicans. Binding of MBL to C. albicans was observed at 5 mg/mL, a concentration within the range of physiological levels (e.g., !0.02-10 mg/mL in southern Chinese persons [39] ) (figure 1A). The binding was markedly reduced in the absence of Ca 2+ (figure 1B) or in the presence of mannan ( figure 1C) .
Influence of MBL on formation of hyphae of C. albicans. Light microscopic analysis revealed that, in terms of the length of hyphae, MBL (5 mg/mL) had no influence on the formation of hyphal structures. C. albicans yeast in the presence or absence of MBL germinated and formed hyphae within 3 h. However, in the presence of MBL, agglutination was induced upon the Deposition of C4 and iC3b on C. albicans. C. albicans yeasts were incubated with 20% serum from each of the 6 MBLdeficient individuals, to which purified MBL (5 mg/mL) was added. The time course of deposition of MBL, C4, and iC3b on the yeast cells was determined by use of flow cytometry ( figure 3A) . No detectable deposition of MBL was found on C. albicans incubated with MBL-deficient serum. Only when exogenous MBL was added to the serum did deposition of MBL become detectable (as early as 30 s), and it attained high levels of deposition over subsequent time points (up to 32 min) (figure 3B). The deposition of an early cleavage product of complement activation, C4, was detected by 1 min of incubation in serum, as shown in figure 3C . The amount of C4 appeared to be significantly enhanced by MBL at 4 min and up to 8 min ( , paired Student's t test of MFI; ). P ! .05 n p 6 In the presence of MBL, deposition of C4 was maximal at 8 min, whereas, in the absence of MBL, deposition of C4 attained its maximal amount slowly over the time course measured. Deposition of opsonic iC3b was detected after 2 min of incubation in serum (figure 3D), and there was an enhancement of deposition in the presence of MBL, reaching significance at 16 min ( , paired Student's t test of MFI; ). P ! .05 n p 6 Opsonophagocytosis of C. albicans by DCs. PKH67-labeled C. albicans yeasts were incubated with 20% MBL-deficient serum supplemented with MBL (0, 1, or 5 mg/mL), for 16 min, the time point at which maximal deposition of opsonic iC3b occurred (figure 3D), followed by incubation with a suspension of DCs for 1 h at 37ЊC. Opsonophagocytosis was measured by use of flow cytometry (figure 4). Opsonization of the yeasts in MBLdeficient serum supplemented with 0 or 1 mg/mL MBL did not influence DC phagocytosis, compared with that for unopsonized yeasts. However, when opsonized in MBL-deficient serum with 5 mg/mL MBL, the relative percentage of yeast-ingested DCs was reduced to (vs. control, , , n 64% ‫ע‬ 4% 93% ‫ע‬ 3% P p .0018 p 4; vs. MBL-deficient serum with 0 mg/mL MBL, , 94% ‫ע‬ 4% , ; paired Student's t test) (figure 4). P ! .001 n p 4
Influence of MBL on growth of C. albicans. Freshly grown C. albicans yeasts were incubated with or without 5 mg/mL MBL and then were incubated with MBL-deficient serum or heatinactivated MBL-deficient serum. As shown in figure 5 , the pretreatment of yeasts with MBL, followed by incubation with either MBL-deficient serum or heat-inactivated MBL-deficient serum separately, resulted in profound inhibition of growth, compared with that observed when no MBL was used in the pretreatment ( , for both unheated and heat-inacti-P ! .0001 vated serum, paired Student's t test of curve areas;
). n p 6
DISCUSSION
The innate immune system is an evolutionarily ancient form of immunity and offers the main resistance to microbial pathogens during the early phase of infection [43] . At present, MBL has been defined as an effector molecule, such as complement, in mediating humoral innate immunity. The third pathway of complement activation initiated by the MBL-MASP complex, known as the lectin pathway, has been described to be highly conserved in evolution as far back as ascidians, our closest invertebrate relatives, suggesting that the lectin-based pathway played a pivotal role in innate immunity before the evolution of an adaptive immune system in jawed vertebrates [44] . Although cell-mediated innate immunity is thought to be a predominant mechanism for the first-line host defense against C. albicans [45] [46] [47] , as a mediator in the highly conserved lectinbased pathway, MBL can strongly bind to C. albicans [37] . In the present study, we have sought to determine the role that MBL plays in the innate defense against C. albicans. The data presented here demonstrate that (1) MBL recognizes C. albicans via its carbohydrate-recognition domain and induces agglutination of the organisms upon their outgrowth of hyphae, (2) MBL mediates complement activation via the lectin pathway and subsequent deposition of opsonic C3 fragment on C. albicans, (3) MBL lacks function as an opsonin for phagocytosis of C. albicans by DCs, and (4) MBL inhibits the growth of C. albicans. These data suggest that MBL plays an important role in the first-line defense against C. albicans without the need for opsonophagocytosis by DCs.
We have demonstrated that MBL binds to C. albicans in a Ca 2+ -dependent manner and that binding is inhibited by competing sugars, such as mannan, implying involvement of the carbohydrate-recognition domain of MBL. Also, MBL does not affect the formation of hyphae of C. albicans but does induce agglutination upon their outgrowth of hyphae, which suggests a novel mechanism of MBL in innate immunity against C. albicans. Steric hindrance by MBL may effectively inhibit the spread of such a virulent form of C. albicans by blocking access to appropriate receptors.
C. albicans activates both the alternative and the classical pathway of complement [48] , and the complement system is important in the resistance against disseminated and cutaneous candidiasis [49] . Antibodies protective against candidiasis require efficient deposition of complement on the fungal surface [50] . In the present study, we have evaluated whether MBL mediates the lectin pathway by initiating the binding of C4 and C3 complement components to C. albicans. The MBL system we used to study complement function involved serum samples from MBL-deficient but generally healthy blood donors, to which exogenous MBL was added, as adapted from previous reports [4, 7] . Thus, each individual, whatever their background levels of complements fixing antibodies to the yeasts, acted as their own control. The addition of MBL to MBL-deficient serum markedly enhanced the binding of C4, reaching its maximal level at 8 min, and also enhanced the subsequent binding of iC3b to C. albicans, with its maximal level reached at 16 min, suggesting that MBL mediates a sequential process in complement activation via the lectin pathway independently of the individual antibodies against the yeasts. It has become clear that various C3 fragments (e.g., C3b, iC3b, and C3d) provide alternative mechanisms for taking up microorganisms via various complement receptors on phagocytic cells [51, 52] . An early study already showed that serum with defective opsonization for phagocytosis by neutrophils has lower deposition of C3b/iC3b on C. albicans [53] , and the presence of this opsonic defect is subsequently linked with low levels of MBL [54] . One would presume that the MBL-mediated enhancement of deposition of opsonic complement on C. albicans, such as that of iC3b, promotes the uptake of the fungal pathogen by phagocytic cells other than neutrophils, such as DCs. Recent studies have demonstrated an important role of DCs in mediating cellular immune response to C. albicans [34] [35] [36] . In the present study, using the same MBL system as that used for the complement activation, we found that MBL did not enhance opsonophagocytosis of the yeasts by human DCs. Furthermore, opsonization by other serum factors, such as the background complements or antibodies in the serum samples from MBL-deficient individuals, appeared not to enhance phagocytosis of C. albicans by DCs. Newman and Holly [34] observed a similar phenomenon in their recent study in which opsonization of C. albicans in pooled human serum did not enhance DC phagocytosis. Our data suggest that MBL, MBL-mediated deposition of complement, and other serum factors lack opsonic function for phagocytosis of C. albicans by DCs. In a recent study, Turner et al. [7] demonstrated that MBL and MBL-mediated increases in opsonic C3 fragments enhance opsonophagocytosis of Staphylococcus aureus by neutrophils. The role of MBL as an opsonin may thus critically depend on the microbial species involved and the types of phagocytes to be interacted with. DCs are capable of phagocytosing C. albicans in the absence of opsonins, presumably via carbohydrate-recognition receptors (also known as C-type receptors), such as mannose receptor [34, 35] .
MBL, at a concentration of 5 mg/mL, was found to decrease phagocytosis of C. albicans by DCs, which can possibly be attributed to the large size of the agglutinated C. albicans complexes induced by MBL upon the outgrowth of hyphae during the incubation period of the phagocytosis assay. The decrease can also be the result of MBL interfering with the recognition of C. albicans by the DC C-type receptors, which mediate subsequent phagocytosis. Similar interference with the uptake of C. albicans was observed on macrophages in an early study using rabbit MBL [55] . Further clarification of whether MBL participates in the regulation of cell-mediated immune response is required if we are to fully understand the exact mechanisms that involve MBL in the modulation of the DC-microbe interaction.
We next considered whether the increased rate of complement activation due to MBL could result in an inhibitory effect on the growth of C. albicans. MBL profoundly inhibited the growth of C. albicans when added to MBL-deficient serum during an incubation period of up to 6 h. Interestingly, we also observed a significant inhibition of growth of C. albicans in the presence of MBL when the serum was heat inactivated, a situation in which complement activation would not occur. This suggests that MBL may have an intrinsic effect in inhibiting fungal growth, but the maximal inhibition we observed with unheated but MBL-supplemented serum indeed demonstrated that complement activation via the lectin pathway is of importance in inhibiting the growth of C. albicans. A recent study has shown that the growth of C. dubliniensis, a Candida species with phenotypical similarity to C. albicans, is decreased in the presence of normal serum but not in the presence of C6/C7-depleted serum [56] , indicating a possible involvement of complement activation up to the terminal complement system (i.e., the generation of the membrane attack complex) in inhibiting the growth of Candida species. It is also possible that the availability of substrate to the organism becomes limited when C. albicans are agglutinated with MBL upon their outgrowth of hyphae during the time of growing. Such inhibition of growth of C. albicans has also been observed with another member of the collectin family, surfactant protein-D [57] .
Lee et al. [58] recently demonstrated that, in mice deficient in MBL-A, resistance to disseminated candidiasis is not altered, suggesting the possibility that MBL deficiency can be compensated by functional redundancy. Two hypotheses have been proposed for the role of MBL. One of these envisages a major role of the protein during the "window of vulnerability" during early life [54] . The alternative hypothesis is that MBL is important on primary contact with an organism, by providing humoral defense before antibody appears-so-called "ante-antibody" [59] . In the present study, we used the MBL system with exogenous MBL added to MBL-deficient serum, which controls for the biological activities due to the background levels of serum factors, such as complements and antibodies. Our observations suggest a predominant role of MBL, among other serum factors, at the early phase of defense against C. albicans. Although MBL deficiency is one of the most common human immunodeficiency states [22] , invasive fungal infection is only seen frequently in certain individuals, such as premature infants, surgical patients, and patients with AIDS [23] [24] [25] [26] [27] [28] [29] ; hence, MBL may be critical only in certain clinical situations. Previous studies have indicated the possible role of MBL in individuals with immunocompromised conditions who are susceptible to Candida infection [60] [61] [62] [63] [64] [65] . Further research targeted at the relative importance of various mechanisms in the host defense against the fungal pathogen will help to identify the possible role of MBL replacement or adjunctive therapy in the clinical situations that render individuals susceptible to fungal infection.
In summary, the present study has documented a direct interaction between C. albicans and MBL, which results in accelerated complement activation via the lectin pathway, leading to inhibition of growth. We conclude that MBL has a significant influence on the host innate immunity against C. albicans without the need for opsonophagocytosis by DCs.
